U.S. Pharmaceuticals & Biotech Blue chip stocks

Axsome Therapeutics

Market Cap: US$13.0b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Ionis Pharmaceuticals

Market Cap: US$12.3b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Elanco Animal Health

Market Cap: US$11.7b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Waters

Market Cap: US$35.1b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Natera

Market Cap: US$32.4b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Insmed

Market Cap: US$21.3b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

BioMarin Pharmaceutical

Market Cap: US$10.6b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Madrigal Pharmaceuticals

Market Cap: US$11.5b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Viatris

Market Cap: US$18.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Alnylam Pharmaceuticals

Market Cap: US$37.7b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Jazz Pharmaceuticals

Market Cap: US$14.2b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

BeOne Medicines

Market Cap: US$29.2b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Royalty Pharma

Market Cap: US$30.9b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Neurocrine Biosciences

Market Cap: US$16.0b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Merck

Market Cap: US$285.1b

Operates as a healthcare company worldwide.

Krystal Biotech

Market Cap: US$10.1b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Gilead Sciences

Market Cap: US$155.8b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.